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Abstract
Background: The relationship between students and the pharmaceutical industry has received substantial attention
for decades. However, there have been few reports on this issue from East Asia. We aimed to investigate Japanese
medical students’ interactions with and attitudes toward the pharmaceutical industry, and to assess the correlation
between exposures to a formal curriculum on drug promotion and perceptions of the appropriateness of the
physician–industry relationship.
Method: We invited all 80 medical schools in Japan to participate. A cross-sectional anonymous survey was
administered to medical students and school staff at the 40 schools that participated. The questionnaire for
students assessed interactions with and attitudes toward the pharmaceutical industry. The questionnaire for
school staff assessed the formal undergraduate curriculum.
Results: Forty of the 80 medical schools in Japan participated. The response rate to the medical student survey
was 74.1%, with 6771 evaluable responses. More than 98% of clinical students had previously accepted a small
gift of stationery, a brochure, or lunch, and significantly higher percentages of clinical than preclinical students
had accepted one or more gifts (P < .001). Among preclinical and clinical students, respectively, 62.7 and 71.9%
believed it was appropriate to accept stationery, and 60.5 and 71.0% thought that attending an industry-sponsored
lunch did not influence clinical practice. Of the 40 participating schools, 13 (33.0%) had a formal curriculum on drug
promotion. A multivariate analysis showed an association between exposure to a formal curriculum and students’
perceptions of the appropriateness of the physician–industry relationship only for gifts of stationery, which
were perceived as inappropriate (OR: 0.81, 95% CI: 0.69–0.95, P = .02).
Conclusions: Most Japanese medical students interact with the pharmaceutical industry and believe that gift
acceptance is appropriate and not influential. This study demonstrated a limited association between students’
perceptions of gift appropriateness and exposure to a formal curriculum.
Keywords: Medical students, Pharmaceutical industry, Conflict of interest, Undergraduate education, Medical education
Background
The physician–industry relationship has received substan-
tial attention for decades. Studies from many countries
show that physician–industry interaction is common, and
that this interaction can lead to higher prescribing costs,
lower prescribing quality, and lower patient trust in physi-
cians [1–5]. In the United States, the Institute of Medicine
(IOM), the American Medical Association (AMA), and the
American College of Physicians (ACP) released stringent
ethical codes in 2008, and the Pharmaceutical Research
and Manufacturers of America (PhRMA) revised their
promotion code in 2009 [6–10]. The Physician Payment
Sunshine Act was also proposed in 2009 [11]. A national
survey in the United States indicated that interactions
between physicians and the pharmaceutical industry chan-
ged after these regulatory initiatives; physician meetings
with sales representatives decreased from three to two per
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month, and the percentage of physicians who received any
gifts decreased from 83 to 71% [12].
Reports from several countries have shown that medical
students also frequently interact with the pharmaceutical
industry [13–17]. In the United States, the Association of
American Medical Colleges (AAMC) released a task force
report in 2008 calling on academic health centers to de-
velop rules for interactions with the industry, as well as
educational programs to teach physicians and students
about this relationship [18]. A follow-up survey in eight
medical schools in the United States showed that the
number of interactions between medical students and the
industry decreased from 4.1 per month in 2003 to 1.6 per
month in 2012, and the percentage of medical students
who received any gifts decreased from 100 to 79% [17].
Further, the percentage of students who agreed with the
statement “It is sometimes okay for medical students to
accept gifts from drug companies because drug companies
have minimal influence on students” decreased from 71%
in 2003 to 39% in 2012. Similarly, the percentage of stu-
dents who believed that information is biased if it is pre-
sented in grand rounds sponsored by drug companies
increased from 67% in 2003 to 83% in 2012. Although
students in 2012 generally had a more skeptical attitude
toward the pharmaceutical industry than in 2003, many
still had a favorable attitude, and 67% of students thought
that information from the industry was useful.
Despite Japan being the second-largest pharmaceutical
market in the world and the expanding pharmaceutical
market in other East Asian countries, there have been
few reports on this issue from East Asia. In Japan, we
reported that Japanese physicians met with sales repre-
sentatives seven times per month and that 96% of them
received a small gift of stationery (such as a pen) and
49% accepted industry-sponsored meals outside their
workplace [19]. In addition, a national survey of Japanese
medical students in 2012 reported that 37% of preclin-
ical and 98% of clinical students had received stationery
such as pens and notepads, and 21% of preclinical and
97% of clinical students had received a lunchbox at pro-
motional meetings for pharmaceutical industry products
[20]. However, attitudes toward interactions between
medical students and the pharmaceutical industry in
East Asian countries have never been evaluated. More-
over, there’s no report about to what extent Japanese
medical students have an opportunity to learn about
physician-industry relationships.
We conducted a cross-sectional survey to investi-
gate Japanese medical students’ interactions with and
attitudes toward the pharmaceutical industry. We also
examined the undergraduate curriculum on drug promo-
tion in Japanese medical schools and assessed the associ-
ation between students’ attitudes and exposure to a formal
curriculum.
Methods
We sent the deans of all 80 medical schools in Japan a
request form for study participation between April and
May 2016. A cross-sectional survey consisting of separate
questionnaires for (I) medical students and (II) school staff
members (regarding the formal curriculum) was conducted
during a single study period. The institutional review board
at Tsukuba University approved the survey protocol.
(I). Survey of medical students
Participants
The target population consisted of all medical students
in Japan. Preclinical and clinical students in medical
schools whose deans approved study participation were
enrolled. In general, medical students receive education
for 6 years in Japan, and are offered a general liberal arts
education for the first 2 years, lectures in basic medicine
before clinical practice in the next 2 years, and clinical
practical training in the last 2 years [21]. Preclinical
students had not yet begun their clinical clerkship pro-
grams, and the persons in charge at each school selected
the school year in which it would be feasible to distrib-
ute and collect the questionnaire within the research
period as the participating year. Clinical students in
Japan are in their fifth and sixth years in medical school.
The 11-month investigation period ran from the begin-
ning of a school year to the end of a school year. Thus
the inclusion of fifth-year students in the study would
have meant that some participants had just started clin-
ical training, whereas others had experienced clinical
training for almost 1 year. We assumed that the less clin-
ical training, the larger the impact of the clinical training
duration on the degree of exposure to the industry.
Therefore, we included only sixth-year clinical students,
as these had all experienced a year of clinical training.
Medical student survey instrument
A 23-item, four-page anonymous questionnaire was de-
veloped after a literature review and discussion among
the authors [13, 15, 17, 19, 20, 22–25]. The question-
naire was not pilot-tested before use. The questionnaire
assessed students’ background information as well as
their interactions with and attitudes toward the pharma-
ceutical industry. The cover page stated the purpose of
the study and confirmed the voluntary nature of partici-
pation and the confidentiality of responses. No incen-
tives were offered for participation.
Interactions with industry
Of the 15 items that assessed exposure to the pharma-
ceutical industry in the survey administered to Japanese
medical students in 2012 [20], five items were also in-
cluded in a previous survey of Japanese physicians [19].
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These questions asked if participants had ever accepted
or attended, as appropriate, the following:
 Stationery, such as a pen or notepad
 A medical textbook or a book of clinical practice
guidelines
 A brochure of a pharmaceutical company’s products
 A lunch provided at a promotional meeting about a
company’s products
 A seminar, workshop, or lecture sponsored by a
pharmaceutical company
Attitudes toward interactions with industry
We asked to what extent students agreed with 13 state-
ments about “informational value,” “bias in information,”
“gift appropriateness,” and “influence on practice” using a
5-point Likert scale (disagree, somewhat disagree, neutral,
somewhat agree, or agree) (Fig. 1). Three items related to
“informational value” and asked whether students thought
information from brochures, from sales representatives,
and in seminars was useful for their future practice. Three
items related to “bias in information” and asked whether
students thought information from brochures, from sales
representatives, and in seminars was biased. Five items re-
lated to “gift appropriateness” and asked whether students
thought it was appropriate for medical students to accept
stationery or textbooks, brochures, or lunch, or to attend
a seminar. The other two items related to “influence on
practice” and asked whether students thought that accept-
ing stationery and lunch influenced physicians’ clinical
practice.
Backgrounds of participants
In addition to sex, age, and years in medical school, we
asked participants whether either of their parents were
medical doctors. We also asked if they had previously re-
ceived any teaching on conflicts of interest related to inter-
actions with the pharmaceutical industry (prior teaching on
the physician–pharmaceutical relationship).
Medical student survey administration
Between May 2016 and March 2017 we sent a set of
questionnaires to the staff or faculty member specified
by the dean of each of the 40 participating schools.
Questionnaires were distributed in a class with required
attendance and collected on that occasion. Each institution
was allowed to choose when to distribute and collect
questionnaires. Leaflets notifying students of the current
regulations regarding physician–industry relationships were
distributed just after the questionnaires were collected to
Fig. 1 Medical students’ attitudes toward the physician-pharmaceutical industry relationship
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relieve any potential unease caused by students’ lack of
knowledge of physician–industry relationships. Completed
questionnaires were returned by mail.
(II). Survey on undergraduate formal curriculum on
drug promotion
A questionnaire about the undergraduate formal cur-
riculum on drug promotion was sent to the staff or fac-
ulty member specified by the dean of each participating
school; this was sent separately from the set of student
questionnaires. We asked whether the school offered a
formal curriculum on drug promotion. If respondents
answered “Yes” to this question, we asked whether the
course was required or elective, and during what year
students took the course. If the questionnaire responses
did not provide sufficient information on whether the
class being surveyed (I) was exposed to such a course,
we asked for confirmation from the person in charge.
Analysis
A questionnaire was considered to be evaluable if it was
returned by the pre-specified deadline (March 31, 2017)
and contained complete information for at least 80% of
the 23 items. Multiple responses to a question for which
a single response was appropriate were considered void
and were not evaluated. To ensure the completeness and
accuracy of data entry, the first author (SS) entered the
data into two separate Microsoft Excel datasheets. The
two datasets were compared and data entry errors were
corrected. SPSS version 23.0 (IBM Corp: Armonk, NY)
was used for all statistical analyses.
Descriptive statistics were calculated for all variables.
The calculation of the percentages reflects the fact that
the denominators for each question differed according
to the number of valid responses. We used Pearson’s
chi-square tests to compare preclinical and clinical stu-
dents in terms of the association between responses to
each item and students’ background information, inter-
actions with the pharmaceutical industry, and attitudes
to industry gifts. Multivariate logistic regression models
(simultaneous method) were used to assess predictive
factors associated with students’ attitudes to the appropri-
ateness of pharmaceutical industry gifts. These attitudes
were the dependent variable and were dichotomized into
appropriate/somewhat appropriate and somewhat in-
appropriate/inappropriate/neutral (the latter was the refer-
ence category). The following independent variables were
used: students’ background characteristics (sex, type of
school, whether either parent was a medical doctor, prior
teaching on the physician–pharmaceutical relationship);
exposure to a formal curriculum on drug promotion as re-
ported by school staff in survey (II); each type of inter-
action with the pharmaceutical industry; and attitudes
toward each interaction in terms of informational value,
bias in information, and influence on practice. We ex-
cluded age, school year, and clinical status (preclinical/
clinical), because these variables were highly correlated
with interactions. We dichotomized schools into national
government-funded (national)/local government-funded
(prefectural) (as the reference category) and private. This
was because ethical codes to restrict gifts from interested
parties are applied in national and prefectural universities,
but not in private universities. Based on the results of
bivariate analysis, students’ attitudes were dichotomized as
follows, with the second category in each case serving as
the reference: agree/somewhat agree and neutral/some-
what disagree/disagree with the statements if the informa-
tion from three sources are useful for “informational
value”; not biased/not very biased and neutral/somewhat
biased/biased for “bias in information”; and not influen-
tial/not very influential and neutral/somewhat influential/
influential for “influence on practice.” For example, in the
multivariable model for appropriateness of stationery, the
independent variables were background characteristics,
prior acceptance of stationery (yes = 1, no = 0), and influ-
ence of stationery on practice (not influential = 1, influen-
tial = 0). Odds ratios (ORs) with 95% confidence intervals
(CIs) were calculated. For all statistical analyses, P values
were 2-tailed and those less than .05 were considered
statistically significant.
Results
Forty (50%) of the 80 medical schools in Japan partici-
pated in the study. Of these, 22 were national (51.2% of
all national schools), 6 were prefectural (75.0% of all pre-
fectural schools), and 12 were private (41.4% of all pri-
vate schools). Thirteen schools (32.5%) had formal
curriculum on drug promotion (Table 1). Of 9132 stu-
dents in the surveyed classes, 7029 (77.0%) responded to
the questionnaire. There were 188 (2.1%) incomplete an-
swer sheets containing answers to fewer than 80% of the
23 items; 40 (0.4%) were blank; and 30 (0.3%) responses
from three classes were judged ineligible because the
survey was not administered according to protocol. Thus
there were 6771 evaluable responses and an overall re-
sponse rate of 74.1%. The response rate of preclinical
Table 1 Characteristics of participating medical schools (N = 40)
Number %
Type national 22 55
prefectural 6 15
private 12 30
Formal curriculum on drug promotion
yes 13 32.5
no 27 67.5
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students was 72.8% (3395/4661) and that of clinical stu-
dents was 75.5% (3376/4471).
Respondent characteristics
The characteristics of the respondents are shown in
Table 2. The mean age of preclinical students was 21.3
years (standard deviation [SD] = 2.81) and that of clinical
students was 25.4 years (SD = 3.14). About two-thirds of
both preclinical and clinical students were men. The
percentage of respondents with at least one parent who
was a medical doctor was approximately 40%; there was
no significant difference on this between preclinical and
clinical students. Of the preclinical and clinical students,
10.8 and 38.9%, respectively, reported that they had
received teaching about conflicts of interest in the phys-
ician–industry relationship (P < .001), and 3.0 and 32.3%
had been exposed to a formal curriculum on drug pro-
motion, which was confirmed by school staff members.
Of students who perceived that they had received educa-
tion on conflicts of interest with the pharmaceutical in-
dustry, 10.6% (n/N = 39/367) of the preclinical group
and 34.4% (450/1308) of the clinical group had been
exposed to a formal curriculum on drug promotion. Of
students who had been exposed to a formal curriculum
on drug promotion, 38.6% (39/101) of the preclinical
group and 41.2% (450/1091) of the clinical group per-
ceived that they had received education on conflicts of
interest with the pharmaceutical industry.
Interaction with the pharmaceutical industry
Of the preclinical students, 1031/3393 (30.4%) had ac-
cepted stationery from the pharmaceutical industry. Fewer
had experienced interactions involving the other four
items: 5.3% for a textbook, 17.6% for a brochure, 13.0% for
lunch, and 8.7% for a sponsored seminar. More than 98%
of clinical students had received stationery, a brochure, or
lunch; 80.1% (2703/3376) had attended a sponsored sem-
inar; but only 26.7% (901/3370) had received a textbook.
The percentage of students who had accepted gifts was
significantly higher for each item in clinical students than
in preclinical students (all P < .001) (Table 3).
Attitudes toward interaction with the pharmaceutical
industry
Students’ attitudes toward their relationship with the
pharmaceutical industry are shown in Fig. 1.
 Informational value
Significantly more clinical than preclinical students
thought that information from the industry was useful.
For example, 2304/3375 (68.3%) of clinical versus 1554/
3394 (45.8%) of preclinical students agreed with the
statement that information from a pharmaceutical com-
pany brochure was useful (P < .001).
 Bias in information
Table 2 Characteristics of respondents
Preclinical (n = 3395) Clinical (n = 3376)
School year, n 1st 705
2nd 1101
3rd 1479
4th 110
6th 3376
Age, mean (standard deviation) 21.3 (2.81) 25.4 (3.14)
n % n %
Sex male 2178 64.2 2160 64.1
female 1214 35.8 1210 35.9
Type of school national 1756 51.7 1819 53.9
prefectural 438 12.9 364 10.8
private 1201 35.4 1193 35.3
One or both parents were a medical doctor yes 1245 36.7 1287 38.2
no 2146 63.3 2081 61.8
Receiving prior teaching on the physician-industry relationship yes 367 10.8 1308 38.9
no 3019 89.2 2057 61.1
Exposure to a formal curriculum on drug promotion yes 101 3.0 1091 32.3
no 3294 97.0 2285 67.7
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A higher percentage of clinical than preclinical students
had opinions about both the presence and absence of bias
in pharmaceutical industry information from brochures or
sales representatives. For example, more clinical than pre-
clinical students believed that information in brochures is
biased (979/3373, 29.0% versus 799/3380, 23.6%, P < .001),
and more clinical students also thought that such infor-
mation is not biased (363/3373, 10.8% versus 169/3380,
5.0%, respectively; P < .001). A similar proportion of
preclinical and clinical students thought that informa-
tion obtained at seminars was biased (764/3376, 22.6%
versus 761/3354, 22.7%, respectively). We found that
7.2% (243/3395) of preclinical students and 18.0% (607/
3376) of clinical students believed that one or more of
the three forms of information was biased. In compari-
son, 3.5% (118/3395) of preclinical students and 8.1%
(274/3376) of clinical students did not believe that
there was any bias in any of the three forms of informa-
tion from industry.
 Gift appropriateness
A substantial proportion of preclinical students thought
it was appropriate to accept stationery (62.7%), a brochure
(59.7%), or lunch (52.0%) or to attend a seminar (62.9%).
A lower proportion of preclinical students thought it
was appropriate to accept a textbook (42.8%). About
10% more clinical than preclinical students thought it
was appropriate to accept each one of the five evaluated
items. More than 20% of preclinical and clinical stu-
dents thought it was inappropriate to accept a textbook.
However, fewer students thought it was inappropriate
to accept stationary (8.0% of preclinical and 6.9% of
clinical students), a brochure (5.7% of preclinical and
3.6% of clinical students), lunch (12.3% of preclinical
and 9.1% of clinical students), and a seminar (3.7% of
preclinical and 2.6% of clinical students). Of students
who perceived that they had received education on con-
flicts of interest with the pharmaceutical industry (n =
1675), there was no difference between the groups with
and without exposure to a formal curriculum on drug
promotion in the percentage of students who thought
that every item from industry was appropriate.
 Influence on practice
More clinical students agreed that accepting stationery
or lunch did not influence physicians’ practice; regarding
lunch, 2391/3367 (71.0%) of clinical versus 2050/3385
(60.6%) of preclinical students held this view (P < .001).
Only about 10% of students thought that accepting
stationery or lunch influenced practice.
Predictors of viewing gifts as appropriate
Table 4 shows the results of multivariate logistic regres-
sion analyses of factors associated with students’ atti-
tudes toward the appropriateness of accepting gifts from
the pharmaceutical industry.
Prior acceptance of any item, the influence on practice
of accepting stationery or lunch, and the informational
value and bias in information in a brochure or a seminar
were positively associated with students’ perceptions of
gift appropriateness. Exposure to a formal curriculum on
drug promotion was negatively associated with students’
perceptions of appropriateness, but only for stationery
(OR: 0.81, 95% CI: 0.69–0.95, P = .01). The perception of
having received prior teaching about the physician–
pharmaceutical industry relationship was associated with
perceived appropriateness of accepting a brochure (OR:
1.27, 95% CI: 1.10–1.46, P < .001) and attending a seminar
(OR: 1.38, 95% CI: 1.20–1.59, P < .001). Attending a pri-
vate school was associated with perceived appropriateness
of accepting a textbook (OR: 1.33, 95% CI: 1.19–
1.48, P < .001) and lunch (OR: 1.17, 95% CI: 1.03–
1.33, P = .01). Sex was not associated with perceived
appropriateness of accepting any type of gift.
Discussion
This study investigated Japanese medical students’ inter-
actions with and attitudes toward the pharmaceutical
industry. Interaction with the industry and a sense that
the industry had minimal influence on practice were
Table 3 Proportions of Japanese medical students who had interacted with the pharmaceutical industry
Preclinical
(n = 3395)*
Clinical
(n = 3376)*
Comparison of proportions, preclinical versus clinical✝
Type of gift or event n % n % P value
Stationery 1031 30.4 3318 98.3 < .001
Medical textbook 181 5.3 901 26.7 < .001
Brochure 598 17.6 3328 98.6 < .001
Lunch provided at a promotional presentation 440 13.0 3332 98.8 < .001
Sponsored seminar 294 8.7 2703 80.1 < .001
✝Pearson’s chi-square test
*Sample size varied by item because of non-respondents. The proportion of non-respondents was less than .18%
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associated with students’ perceptions that gift acceptance
was appropriate. Students with exposure to a formal cur-
riculum on drug promotion were more likely to think
that it was appropriate to accept stationery, but not a
textbook, a brochure, lunch, or a seminar.
More than 90% of Japanese clinical students had accepted
stationery or lunch and 80% had attended a sponsored
seminar. Further, interactions with the pharmaceutical in-
dustry were reported more commonly by clinical students
than by preclinical students; fewer than 30% of the latter
had had such interactions. Our observations are consistent
with recent reports from other countries on the overall
frequency of interactions [13, 26] and the trend toward
higher frequencies in clinical students [20, 23, 26, 27]. The
higher rate at which clinical students in this study inter-
acted with the industry was similar to the pattern seen in
Japanese physicians in a previous survey, in which 96% of
respondents received stationery, and 80 and 93% attended
industry-sponsored educational events inside and outside
the workplace, respectively [19].
A survey at Washington University in the United
States demonstrated that by the end of their first year,
one-third of students had accepted a meal offered by the
pharmaceutical industry [28]. The present study showed
that one in three preclinical students had received
stationery and one in eight had accepted lunch. In Japan,
two-thirds of schools include early clinical immersion at
community clinics, community hospitals, or nursing homes
in their first-year curriculum [29]. Our findings suggest that
education about the relationship with industry is required
before students begin clinical immersion programs.
In this study, 45.8 and 68.3% of preclinical and clinical
students, respectively, thought that information in pharma-
ceutical company brochures was useful, which is within the
range found in recent studies (30–70%) [13, 15, 17, 24]. We
found that 20–30% of students perceived bias in informa-
tion received from the industry, a rate much lower than the
reported 70–90% of students in the United States who
considered that sponsored grand rounds were biased
[13, 17, 22, 24]. One possible reason for this difference
is the low level of education on critical appraisal of
drug promotion in Japan. Our survey of formal curric-
ula on drug promotion (survey II) showed that only
6.8% (3/44) of schools in Japan had a formal curriculum
teaching critical appraisal of drug promotion, as re-
ported in our paper on formal curricula in Japan [30].
This contrasts with North American countries where
79% of schools had such curricula [31]. In the present
study, 62.7% of preclinical and 71.8% of clinical stu-
dents thought that accepting stationery was appropri-
ate. These percentages are higher than those in recent
studies in which approximately half of respondents
considered it appropriate to accept a meal, book, or
small gift [13, 15, 17, 22], and they are compatible with
the findings of other studies showing that clinical stu-
dents are more likely than preclinical students to con-
sider it appropriate to accept industry gifts [32, 33].
Regarding the perception of the influence of gifts, fewer
than 10% of Japanese students in this study believed
that accepting stationery or lunch would influence their
clinical practice. This proportion is much lower than re-
ported in studies from other countries, which indicate that
25–70% of students thought that receiving gifts or food in-
creased the chance that their fellow students would eventu-
ally prescribe the company’s drugs [13, 15, 17, 23–25]. In
one previous survey, as few as 16% of Japanese physicians
stated that gifts from sales representatives had an unfavor-
able impact on prescriptions [19], and students’ attitudes
toward the influence of gifts may be interpreted as a reflec-
tion of the views of their instructors. The lack of education
about drug promotion in Japan noted above may also have
contributed to these lower percentages [30].
The multiple regression analysis showed that partici-
pation in physician–industry interactions contributed to
students’ perceptions of the appropriateness of industry
gifts. This is in accord with a previous study showing
that exposure to physician–industry interactions led to
positive attitudes to industry; for example, feeling grate-
ful for having drug-related information provided by a
sales representative (odds ratio = 3.0) [34]. Research has
also shown that interaction with the industry reduces
skepticism and hesitation and increases physicians’ confi-
dence that they will not be influenced by these interactions
[35, 36]. The association between physician–industry inter-
action and attitudes to the appropriateness of such interac-
tions found here is consistent with associations reported in
recent studies. Sierles et al. assessed the association be-
tween skepticism (measured by responses to items on infor-
mational value, bias in information, and influence on
practice) and attitudes about the appropriateness of receiv-
ing gifts, and reported that more skeptical students were
less likely to think that gifts were appropriate [13, 17]. The
current study showed that attitudes to the influence of in-
dustry gifts on practice had higher odds ratios than did in-
teractions, informational value, and bias in information.
This indicates that the lack of awareness of influence on
practice is a more powerful determinant of students’ per-
ception that gift giving is appropriate than other variables.
Educational programs that aim to increase awareness of
these influences are likely to be more effective at changing
students’ attitudes.
There was a difference in the percentage of students
who answered that they were educated about physician–
industry relationships and the percentage of students
who had actually been exposed to a formal curriculum
on this topic. This may be because medical students
perceive informal discussions with their faculty instruc-
tors during clinical clerkships as education on this topic
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[26, 37, 38]. Students’ perception that they had received
such teaching was positively associated with the view
that it was appropriate to accept stationery, a brochure,
or attend a seminar, indicating that the education that
students believed they were exposed to generated favorable
attitudes toward the pharmaceutical industry. This in-
terpretation is supported by the lack of a difference in
the perception of appropriateness between students
with and without exposure to a formal curriculum among
those who perceived that they had been educated about
drug promotion. These results confirm that role modeling
is an important component of the informal curriculum in-
fluencing students’ attitudes, as also indicated in recent
studies [13, 14, 39].
This study has several limitations. Although the back-
ground characteristics of the respondents, such as sex,
type of school, and age, did not differ from national
statistics [29], only about half of all medical schools in
Japan participated, raising concerns about sampling bias.
Many schools declined to participate because of the sur-
vey contents; others may have accepted more financial
support from the pharmaceutical industry or may have
had negative views on educating students about the rela-
tionship with the industry. Second, the respondents may
have expressed socially desirable responses despite ano-
nymity and self-administration. Third, we did not confirm
whether individual participants had actually participated in
a formal curriculum. Instead, we asked school officers if the
class students belonged to had participated in the program,
and because the programs were all required courses, we
considered the students to have been exposed. Fourth, the
contents of the formal curricula varied; the effects of these
programs could be assessed more accurately if their con-
tents were standardized, e.g., based on specific guidelines
[40]. Fifth, 188 of 7029 students (2.7%) returned partial re-
sponses and their data were therefore excluded from the
analysis. However, an analysis of the whole data that
included the partial responses produced results that were
essentially unchanged. Sixth, this was a cross-sectional
survey and we cannot infer causal relationships between in-
teractions and attitudes. Finally, the results may not be
generalizable to medical education in other settings. Some
research suggests that cultural differences need to be taken
into account when considering education on medical pro-
fessionalism [41], as relationships with the pharmaceutical
industry are likely to be influenced by social and cultural
background. Drawing on experiences from Western coun-
tries is helpful when considering educational interventions
and implementation of regulations, but such experiences
may not always apply to East Asian countries because of
different cultural backgrounds. The current study is espe-
cially helpful when considering educational interventions
and implementation of regulations in the East Asian coun-
tries. Our findings may also be useful to inform research on
educational interventions in other countries in which
pharmaceutical sales are expanding.
Future curriculum reforms would benefit from add-
itional studies that investigate when, by whom, and how
students are informally educated about the relationship
with the pharmaceutical industry and that examine the
contents of such informal teaching and its influence on
students’ attitudes and behaviors.
Conclusions
We report here Japanese medical students’ interactions
with and attitudes toward the pharmaceutical industry.
We demonstrated an association between students’ interac-
tions, skeptical attitudes, and perceptions of education on
the physician–industry relationship, and students’ opinions
about gift appropriateness. These results show the associ-
ation between students’ lack of awareness of the potential
influence of gifts and their perception of the appropriate-
ness of gifts. The association between exposure to a formal
curriculum on drug promotion and students’ perceptions
of gift appropriateness was limited. There have been no
efforts in Japan to establish professional guidelines on
the physician–industry relationship. We hope that this
study promotes discussion of the development of ap-
propriate regulations.
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